These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


117 related items for PubMed ID: 8432380

  • 21. Biological activity of platelet activating factor-amidophosphonate (PAF-AP), a novel phosphonolipid selective inhibitor of platelet activating factor (PAF).
    Steiner M, Landolfi R, Motola NC, Turcotte JG.
    Biochem Biophys Res Commun; 1985 Dec 31; 133(3):851-5. PubMed ID: 3936503
    [Abstract] [Full Text] [Related]

  • 22. ADP-stimulated fibrinogen binding is necessary for some of the inositol phospholipid changes found in ADP-stimulated platelets.
    Vickers JD.
    Eur J Biochem; 1993 Aug 15; 216(1):231-7. PubMed ID: 8396029
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Platelet hypersensitivity in cholesterol-fed rabbits: enhancement of thromboxane A2-dependent and thrombin-induced, thromboxane A2-independent platelet responses.
    Gross PL, Rand ML, Barrow DV, Packham MA.
    Atherosclerosis; 1991 May 15; 88(1):77-86. PubMed ID: 1878012
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A high concentration of ADP induces weak platelet granule secretion independently of aggregation and thromboxane A2 production.
    Lantz N, Hechler B, Ravanat C, Cazenave JP, Gachet C.
    Thromb Haemost; 2007 Nov 15; 98(5):1145-7. PubMed ID: 18000625
    [No Abstract] [Full Text] [Related]

  • 31. Verapamil inhibits phosphatidic acid formation and modifies phosphoinositide metabolism in stimulated platelets.
    Homa ST, Khan SN, Conroy DM, Speak AE, Smith AD.
    Eur J Pharmacol; 1990 Jul 17; 182(3):457-64. PubMed ID: 2171946
    [Abstract] [Full Text] [Related]

  • 32. Control and interrelation of aggregation and secretion; the roles of Ca2+, diacylglycerol and thromboxane with particular reference to ADP stimulation.
    Hallam TJ, Simpson AW, O'Connor N, Rink TJ.
    Adv Exp Med Biol; 1985 Jul 17; 192():145-62. PubMed ID: 3010663
    [No Abstract] [Full Text] [Related]

  • 33. Secretory mechanisms. Behaviour of adenine nucleotides during the platelet release reaction induced by adenosine diphosphate and adrenaline.
    Holmsen H, Day HJ, Setkowsky CA.
    Biochem J; 1972 Aug 17; 129(1):67-82. PubMed ID: 4675006
    [Abstract] [Full Text] [Related]

  • 34. Antithrombogenic effects of calcium channel blockers: synergism with prostacyclin and thromboxane synthase inhibitors.
    Onoda JM, Sloane BF, Honn KV.
    Thromb Res; 1984 Jun 01; 34(5):367-78. PubMed ID: 6377570
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. HA-29: an inhibitor of thromboxane A2 formation with antagonism of thromboxane A2/prostaglandin endoperoxide receptor in rabbit platelets.
    Lin CH, Kuo SC, Huang LJ, Huang TF, Teng CM.
    Thromb Res; 1992 Apr 01; 66(1):61-73. PubMed ID: 1412184
    [Abstract] [Full Text] [Related]

  • 37. Inhibition of thromboxane A2 synthesis in human platelets by coagulation factor Xa.
    Sinha AK, Rao AK, Willis J, Colman RW.
    Proc Natl Acad Sci U S A; 1983 Oct 01; 80(19):6086-90. PubMed ID: 6577468
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The relative degradation of [14C]eicosapentaenoyl and [3H]arachidonoyl species of phosphatidylinositol and phosphatidylcholine in thrombin-stimulated human platelets.
    Weaver BJ, Holub BJ.
    Biochem Cell Biol; 1986 Dec 01; 64(12):1256-61. PubMed ID: 3032217
    [Abstract] [Full Text] [Related]

  • 40. The correlation between Ca2+ influx and inositol 1, 4, 5-trisphosphate (IP3) formation in platelets stimulated by various agonists.
    Uemura Y, Sakon M, Kawasaki T, Shiba E, Kambayashi J, Mori T.
    Biochem Int; 1990 Dec 01; 20(5):853-61. PubMed ID: 2112382
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.